Inflammation in atrial fibrillation

J Am Coll Cardiol. 2012 Dec 4;60(22):2263-70. doi: 10.1016/j.jacc.2012.04.063.


Atrial fibrillation (AF) is associated with increased risk for stroke and systemic embolism. There is plausible evidence linking inflammation to the initiation and perpetuation of AF and AF-related thrombosis. Various inflammatory markers (C-reactive protein, tumor necrosis factor-α, interleukin-2, interleukin-6, and interleukin-8) have been associated with AF. Proposed mechanisms linking inflammation and the prothrombotic AF state include endothelial activation/damage, production of tissue factor from monocytes, increased platelet activation, and increased expression of fibrinogen. The present review aims to provide an update on the association of inflammation and AF, including the impact of inflammatory markers on clinical presentation and outcome of AF patients.

Publication types

  • Review

MeSH terms

  • Animals
  • Atrial Fibrillation / blood
  • Atrial Fibrillation / epidemiology*
  • Atrial Fibrillation / pathology*
  • Biomarkers / blood
  • Case-Control Studies
  • Humans
  • Inflammation / blood
  • Inflammation / epidemiology
  • Inflammation / pathology
  • Inflammation Mediators / physiology*
  • Risk Factors


  • Biomarkers
  • Inflammation Mediators